» Authors » Claudia Mescoli

Claudia Mescoli

Explore the profile of Claudia Mescoli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 116
Citations 1424
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Angriman I, Colangelo A, Mescoli C, Fassan M, DInca R, Savarino E, et al.
Front Surg . 2022 Aug; 9:911044. PMID: 35959125
Background: In 10%-20% of cases it is impossible to make a differential diagnosis between ulcerative colitis and Crohn's colitis. A 50% failure rate of J pouch ilea-anal anastomosis is observed...
12.
Marletta S, Pantanowitz L, Malvi D, Novelli L, Mescoli C, Cardillo M, et al.
Acad Pathol . 2022 Aug; 9(1):100047. PMID: 35941875
Despite increased use of digital pathology, its application in the transplantation setting remains limited. One of the restraints is related to concerns that this technology is inadequate for supporting diagnostic...
13.
Grillo F, Carlin L, Remo A, Fassan M, Mescoli C, Campora M, et al.
J Clin Pathol . 2022 Jun; 76(3):202-205. PMID: 35701140
Dasatinib is a second-generation multityrosine kinase inhibitor used in the first-line and second-line treatment of Philadelphia chromosome-positive leukaemia. The most frequent type of Dasatinib-induced intestinal injury is haemorrhagic colitis; other...
14.
DAmico F, Mescoli C, Caregari S, Pasquale A, Billato I, Alessandris R, et al.
Cancers (Basel) . 2022 Apr; 14(7). PMID: 35406452
In resected perihilar cholangiocarcinoma (PHC), positive ductal margin (DM) is associated with poor survival. There is currently little knowledge about the impact of positive radial margin (RM) when DM is...
15.
Rizzato M, Brignola S, Munari G, Gatti M, Dadduzio V, Borga C, et al.
Eur J Cancer . 2022 Mar; 166:165-175. PMID: 35303508
Aim: FGFR2 rearrangements have been identified as a novel therapeutic target of biliary tract cancer (BTC). However, reliable prevalence estimates of this molecular alteration and its prognostic role have not...
16.
Gambella A, Mastracci L, Caporalini C, Francalanci P, Mescoli C, Ferro J, et al.
Pathologica . 2022 Feb; 114(1):89-103. PMID: 35212319
Pediatric liver transplantation represents a safe and long-lasting treatment option for various disease types, requiring the pathologist's input. Indeed, an accurate and timely diagnosis is crucial in reporting and grading...
17.
Neri F, Eccher A, Rigotti P, Girolami I, Zaza G, Gambaro G, et al.
J Pathol Inform . 2021 Dec; 12:41. PMID: 34881096
Background: In the setting of kidney transplantation, histopathology of kidney biopsies is a key element in the organ assessment and allocation. Despite the broad diffusion of the Remuzzi-Karpinski score on...
18.
Marzollo A, Bresolin S, Colavito D, Cani A, Gaio P, Bosa L, et al.
Front Pediatr . 2021 Oct; 9:703056. PMID: 34692603
Nodular lymphoid hyperplasia (NLH) is a lymphoproliferative disease caused by non-clonal expansion of lymphoid cells in the gut mucosa. Little is known about the pathogenesis of NLH, which is often...
19.
Cali B, Agnellini A, Cioccarelli C, Sanchez-Rodriguez R, Predonzani A, Toffolo G, et al.
Front Immunol . 2021 Oct; 12:718098. PMID: 34675917
Reactive oxygen species, including RNS, contribute to the control of multiple immune cell functions within the tumor microenvironment (TME). Tumor-infiltrating myeloid cells (TIMs) represent the archetype of tolerogenic cells that...
20.
Galuppini F, Fassan M, Mastracci L, Gafa R, Lo Mele M, Lazzi S, et al.
Pathologica . 2021 Jul; 113(3):218-229. PMID: 34294939
The 2019 WHO classification of digestive system tumors significantly reformed the classificatory definition of serrated lesions of the colorectal mucosa and added new essential diagnostic criteria for both conventional adenomas...